ORINF (Orion Oyj) Total Operating Expense: $694 Mil (TTM As of Mar. 2026)


ORINF Orion Oyj ORINF
99 GF Score
Price $82.75
GF Value $81.64
! 3 Warning Signs
View Full Analysis

What is Orion Oyj Total Operating Expense?

Orion Oyj ORINF +4.81% 99 Total Operating Expense is $694 Mil as of Mar. 2026. GuruFocus rates ORINF with a GF Score™ of 99/100 and a GF Value™ of $81.64. The stock has 3 warning signs investors should review.

Orion Oyj's Total Operating Expense for the three months ended in Mar. 2026 was $161 Mil. Orion Oyj's Total Operating Expense for the trailing twelve months (TTM) ended in Mar. 2026 was $694 Mil.

Orion Oyj Total Operating Expense Related Terms

Orion Oyj Total Operating Expense Historical Data

* Premium members only.

The historical data trend for Orion Oyj's Total Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Orion Oyj Total Operating Expense Chart

Orion Oyj Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Operating Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only 402.03 440.04 428.03 556.86 683.84

Orion Oyj Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Total Operating Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 134.05 165.74 156.34 211.36 161.04
ORINF
99GF Score
Orion Oyj ORINF
Total Operating Expense is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Orion Oyj Total Operating Expense Calculation

Total Operating Expense is the primary recurring expense associated with central operations that are incurred in order to generate sales.


Total Operating Expense for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $694 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Total Operating Expense of $694 Mil mean?
Orion Oyj (ORINF) has a Total Operating Expense of $694 Mil as of Mar. 2026. Total operating expense is the primary recurring expense associated with central operations. View historical data on Orion Oyj and its competitors.
Is Orion Oyj's Total Operating Expense too high?
Orion Oyj's current Total Operating Expense is $694 Mil. Overall, Orion Oyj has a GF Score™ of 99/100, reflecting its overall financial health beyond just this single metric.
How does Orion Oyj's Total Operating Expense compare to LLY and JNJ?
Orion Oyj's Total Operating Expense of $694 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Operating Expense for a Drug Manufacturers company?
A good Total Operating Expense depends on the Drug Manufacturers industry context. However, Total Operating Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Operating Expense mean?
A high Total Operating Expense can signal that a stock is expensive relative to its fundamentals. Total operating expense is the primary recurring expense associated with central operations. View historical data on Orion Oyj and its competitors. Orion Oyj's current Total Operating Expense is $694 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Orion Oyj stock overvalued right now?
Orion Oyj (ORINF) has a current Total Operating Expense of $694 Mil. The stock's GF Value™ is $81.64, compared to a current price of $82.75 — trading 1.4% above its estimated fair value. The current Total Operating Expense is $694 Mil. Orion Oyj's overall GF Score™ is 99/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Operating Expense calculated?
Total Operating Expense is calculated from a company's financial statements. For Orion Oyj (ORINF), the current Total Operating Expense is $694 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Orion Oyj (ORINF) Overvalued in 2026?

Based on GuruFocus' analysis, Orion Oyj stock appears to be overvalued. The current stock price of $82.75 is trading 1.4% above its estimated GF Value™ of $81.64.

Key valuation signals for ORINF:

  • Total Operating Expense: $694 Mil
  • GF Value™: $81.64 vs. price of $82.75 (1.4% above fair value)
  • GF Score™: 99/100 with 3 warning signs

No single metric tells the full story. See the ORINF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Orion Oyj Business Description

Address Orionintie 1, Espoo, FIN, FI-02200
Orion Oyj is a globally operating Finnish pharmaceutical company that develops, manufactures, and markets human and veterinary pharmaceuticals and active pharmaceutical ingredients. The company predominantly focuses on treatments for central nervous system disorders, oncology, and respiratory diseases. Orion's customers include specialists and general practitioners, veterinarians, pharmacies, hospitals, and laboratories. The company mainly serves Finland but also has a presence in other European countries, North America and other countries.
99GF Score

Get the complete analysis for ORINF

Total Operating Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$82.75
Price
$81.64
GF Value